MedTrace Logo

Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01512043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2014-05-06

No results posted yet for this study

Summary

There is a demand for explorative and comparative studies on various non-pharmaceutical efforts in treating and helping chronic obstructive pulmonary disease patients. This study has been developed in light of this need. The main purpose of the project is to test whether a device guided breathing control system can decreasing the feeling of breathlessness in patients with moderate stage and severe stage of COPD. In addition the study could shed light on whether a reduced feeling of breathlessness can lead to improved physical function, and less experience of other symptoms (I.e., depression, anxiety, sleeping difficulties, fatigue, pain) and provide a better quality of life for patients with COPD.

Conditions

Interventions

BEHAVIORAL

Breathing control

Practice of device guided breathing control twice a day for four weeks.

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • Norwegian Foundation for Health and Rehabilitation

    collaborator OTHER

  • University of Bergen

    collaborator OTHER

  • Lovisenberg Diakonale Hospital

    lead OTHER

Principal Investigators

  • Astrid K Wahl, Professor · University of Oslo

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01512043 on ClinicalTrials.gov